Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4787285 | 5897259 | I | 4787285-7 | 20050916 | 20050930 | EXP | 12440 | MAYNE PHARMA PTY LTD. | 1 | DY | M | N | 20050929 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4787285 | 1006480334 | PS | PAMIDRONATE DISODIUM | 1 | D | U | 75841 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4787285 | 1006480334 | OSTEOGENESIS IMPERFECTA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4787285 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4787285 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 4787285 | HYPOCALCAEMIA |
| 4787285 | MATERNAL DRUGS AFFECTING FOETUS |
| 4787285 | NEONATAL DISORDER |
| 4787285 | OSTEOGENESIS IMPERFECTA |
| 4787285 | SCLERAL DISCOLOURATION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4787285 | FGN |
| 4787285 | HP |
| 4787285 | LIT |
| 4787285 | OTH |
Therapies reported
| no results found |